Literature DB >> 12964420

Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met).

Ole B Suhr1, Intissar Anan, Katrine Riklund Ahlström, Anders Rydh.   

Abstract

Liver transplantation is an accepted treatment of familial amyloidotic polyneuropathy (FAP), Portuguese type (Val30Met), and the outcome so far seems promising. Gastric retention with nausea and vomiting are common complications of the disease, and may interfere with immuno-suppression therapy and prolong recovery after liver transplantation. The aim of this study was to assess the frequency of gastric retention in FAP patients and to evaluate the impact liver transplantation has on gastric emptying. Twenty-two patients, who had undergone liver transplantation, and had been re-examined for gastric retention after the procedure, were included in the study. Gastric emptying was recorded by scintigraphy after the ingestion of a 99m-technetium (99mTc)-labelled meal (omelette). The half-time (T50) of the emptying phase was calculated. Gastrointestinal symptoms before and after transplantation were recorded, and the majority of patients were also subjected to an upper endoscopic examination, where the presence of solid residual in the stomach was regarded as consistent with gastric retention. A high frequency of gastric retention was noted among the patients both before and after transplantation, and no significant improvement for the group was noted, even though decreased gastric emptying was noted for patients with a duration of the disease for less that 4 years. Patients who improved their nutritional status after transplantation had a faster gastric emptying than those who deteriorated. From our findings it can be concluded that gastric retention is a common complication of FAP and that gastric emptying in patients with longstanding disease (> or = 4 years) is unchanged after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964420     DOI: 10.3109/13506120309041734

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  9 in total

1.  Ten-year follow-up of peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation.

Authors:  Yoshio Shimojima; Hiroshi Morita; Sachio Kobayashi; Yo-ichi Takei; Shu-ichi Ikeda
Journal:  J Neurol       Date:  2008-05-20       Impact factor: 4.849

2.  Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience.

Authors:  Andrew J Cowan; Martha Skinner; David C Seldin; John L Berk; David R Lichtenstein; Carl J O'Hara; Gheorghe Doros; Vaishali Sanchorawala
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 3.  Systemic amyloidosis and the gastrointestinal tract.

Authors:  Prayman T Sattianayagam; Philip N Hawkins; Julian D Gillmore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

4.  Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Authors:  J Wixner; P Karling; A Rydh; R Hörnsten; U Wiklund; I Anan; O B Suhr
Journal:  Neurogastroenterol Motil       Date:  2012-08-16       Impact factor: 3.598

5.  Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Torbjörn Sundström; Pontus Karling; Intissar Anan; Ole B Suhr
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

6.  THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.

Authors:  Jonas Wixner; Rajiv Mundayat; Onur N Karayal; Intissar Anan; Pontus Karling; Ole B Suhr
Journal:  Orphanet J Rare Dis       Date:  2014-04-27       Impact factor: 4.123

7.  Post hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis.

Authors:  Ole B Suhr; Isabel M Conceição; Onur N Karayal; Francine S Mandel; Pedro E Huertas; Bo-Göran Ericzon
Journal:  Neurol Ther       Date:  2014-12-11

8.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

Review 9.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.